beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles
G. Moreno-bueno et al., beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles, BR J DERM, 145(4), 2001, pp. 576-581
Background beta -catenin functions in signal transduction in the Writ signa
lling pathway, which has recently been implicated in hair follicle (HF) mor
phogenesis. beta -catenin gene mutations affecting exon 3 have been reporte
d in a high percentage of human pilomatrixomas. However, the expression pat
tern of beta -catenin in human HFs and pilomatrixomas has not been reported
.
Objectives To analyse immunohistochemically the expression pattern of beta
-catenin in normal anagen HFs and in 40 human pilomatrixomas.
Methods In 11 of these tumours we also studied exon 3 beta -catenin gene mu
tations by polymerase chain reaction and direct sequencing. As these mutati
ons have been related to a replication error (RER) phenotype in other tumou
r types, we explored whether or not this association also occurs in pilomat
rixomas.
Results beta -catenin was expressed in the cell membranes of the outer and
inner root sheaths and in matrix cells located at the base and periphery of
the HF bulb. However, central matrix cells that differentiate into cortica
l cells, cortical and cuticular cells expressed beta -catenin in the nucleu
s, suggesting a role in signal transduction. In addition, some fibroblasts
of the dermal papilla also showed nuclear expression of (beta -catenin. All
40 analysed pilomatrixomas showed intense nuclear and cytoplasmic beta -ca
tenin expression in proliferating matrix (basaloid) cells. In areas of matu
ration, transitional cells mainly showed cytoplasmic and membranous express
ion of beta -catenin. while only a few cells retained nuclear expression. S
hadow or ghost cells did not show beta -catenin expression. Three of 11 tum
ours (26%) had beta -catenin mutations. All three had the same heterozygote
mis-sense mutation: a G to T change affecting the first nucleotide at codo
n 32 (D32Y). None of the 11 tumours studied had a positive RER phenotype.
Conclusions Present and previous studies suggest that the Wnt/beta -catenin
/Tcf-Lef pathway is activated in normal matrix cells of the HF to induce di
fferentiation to the hair shaft. Additionally, the beta -catenin mutation i
n matrix cells of the HF stabilizes beta -catenin protein, which translocat
es into the nucleus, where it activates of gene transcription together with
lymphoid enhancer factor-1 producing pilomatrixoma. These mutations occur
without an underlying defect in DNA mismatch repair.